A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD

Clinical trial NCT07158775 · RECRUITING

Trial details

NCT number: NCT07158775
Sponsor: Bionic Sight LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)

Start date: 2026-01-08
Primary completion: 2027-12-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.